cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Qiagen Nv
10 own
8 watching
Current Price
$46.07
$1.75
(3.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10,361.91M
52-Week High
52-Week High
47.44000
52-Week Low
52-Week Low
39.03000
Average Volume
Average Volume
2.2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
35.368
iconMarket Capitalization10,361.91M
icon52-Week High47.44000
icon52-Week Low39.03000
iconAverage Volume2.2M
iconDividend Yield--
iconP/E Ratio35.368
What does the Qiagen Nv do?
QIAGEN N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights worldwide. It offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technology solutions. The company provides Ingenuity Variant Analysis, a cloud-based platform that interprets data from next-generation sequencing (NGS) analysis; QIAGEN Clinical Insight, an evidence-based decision support solution; CLC Genomics Workbench for the analysis and visualization of data from various NGS platforms; and GeneGlobe, a Web-based portal that enables researchers to search and select gene- and pathway-specific solutions from pre-designed and custom PCR assay kits, NGS assay panels, and other products. It also offers instrumentation systems for laboratories to perform nucleic acid sample preparation, assay setup, target detection, and interpretation of genomic information. The company's automation platforms include QIAsymphony, a modular system; GeneReader NGS System, a sample to insight NGS solution for laboratories; Modaplex, a multimodal automation system; QIAcube, a sample processing instrument; EZ1 Advanced XL for automated nucleic acid purification; QIAxcel for nucleic acid separation; QIAscout that enables researchers to select and isolate viable single cells; PyroMark, a detection platform that enables real-time analysis and quantification of genetic mutations and DNA methylation patterns; QIAgility, a benchtop instrument; and ESEQuant instruments that enable optical measurement for point of need molecular testing in healthcare and other applications. It serves molecular diagnostics, applied testing, pharma, and academia customers. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Read More
News & Events about Qiagen Nv.
Globe Newswire
1 year ago
Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Senior Unsecured Convertible Notes due 2023 (the "2023 Notes") ...
Zolmax
1 year ago
Sumitomo Mitsui Trust Holdings Inc. increased its position in Qiagen (NYSE:QGEN Get Rating) by 10.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 452,524 shares of the companys stock after buying an ...
Globe Newswire
1 year ago
Launch of cell-free DNA (cfDNA) next-generation sequencing kits to test liquid biopsies // Study to demonstrate QIAGENs expertise in detecting disease-relevant cfDNA mutations // New pan-cancer panels for digital PCR platform QIAcuity to be launched in fall 2023Venlo, the Netherlands, April 14, 2023...
Globe Newswire
1 year ago
SBTi has validated the QIAGEN targets to reach net-zero greenhouse gas (GHG) emissionsVenlo, The Netherlands, March 27, 2023 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its emissions reduction targets have been validated by the Science Based ...
Business Wire
1 year ago
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a strategic partnership with Servier, a global pharmaceutical group, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of the...
Frequently Asked Questions
Frequently Asked Questions
What is Qiagen Nv share price today?
plus_minus_icon
Can Indians buy Qiagen Nv shares?
plus_minus_icon
How can I buy Qiagen Nv shares from India?
plus_minus_icon
Can Fractional shares of Qiagen Nv be purchased?
plus_minus_icon
What are the documents required to start investing in Qiagen Nv stocks?
plus_minus_icon
What is today’s traded volume of Qiagen Nv?
plus_minus_icon
What is today’s market capitalisation of Qiagen Nv?
plus_minus_icon
What is the 52-Week High and Low Range of Qiagen Nv?
plus_minus_icon
What percentage is Qiagen Nv down from its 52-Week High?
plus_minus_icon
What percentage is Qiagen Nv up from its 52-Week Low?
plus_minus_icon
Current Price
$46.07
$1.75
(3.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sensata Technologies Holding NV
Sensata Technologies Holding NV
$30.97
$0.08 (0.26 %)
Pentair plc
Pentair plc
$107.89
$-0.35 (-0.32 %)
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$339.35
$-6.25 (-1.81 %)
Steris Corp.
Steris Corp.
$214.22
$-1.41 (-0.65 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sensata Technologies Holding NV
Sensata Technologies Holding NV
$30.97
$0.08 (0.26 %)
Pentair plc
Pentair plc
$107.89
$-0.35 (-0.32 %)
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$339.35
$-6.25 (-1.81 %)
Steris Corp.
Steris Corp.
$214.22
$-1.41 (-0.65 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00